Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Knowing when to modify your financial plan is essential for optimal results. Discover key indicators that signal it's time for adjustments.
22,705 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
A batch of midweek analyst notes lifts several big names, steering markets higher as investors weigh price targets, e...
Warren Buffett resurfaces on CNBC as Berkshire Hathaway shares retreat, highlighting leadership transition questions ...
California lawmakers return from summer break to push condo safety reforms, focusing on a true right-to-repair proces...
A surge in crypto funding surging again accompanies a strategic pivot by major VCs toward infrastructure and tokenize...
Pi Network confirms the long-anticipated network update finally, announcing a successful v19.6 migration and outlinin...
Ethereum co-founder Vitalik Buterin escalated ETH sales as prices retreat. On-chain data show 1,869 ETH sold for abou...
Ethereum tests $1,800 as Vitalik Buterin liquidates more than 10,700 ETH since early February. The move sparks renewe...
Coinbase stock has fallen sharply this year, yet a cadre of analysts believes a turnaround is possible as the company...
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
A rumored $111 billion Paramount Warner Bros' deal could fuse studios, streaming, and networks under a private group,...
Credo Technology is set to report after the close, with investors watching margins and guidance as the stock prices i...